University of Lucerne, Faculty of Health Sciences and Medicine, Universitäres Forschungszentrum Gesundheit und Gesellschaft
Lucerne, Canton of Lucerne, 6002, Switzerland
NCT Number: NCT06540911
The aim of our clinical trial (2024-01285) is to determine how an individualized physical back training program affects physical functioning and back pain. The results will help identify the most effective treatments for low back pain. This feasibility study (2024-01284) aims to conduct a test run of the clinical trial. The main questions are:
* Do all procedures run smoothly? * Does the back training program improve physical functioning? * Does the back training program reduce back pain?
Participants will:
* Follow a back training program for 4 weeks. * Attend group exercise sessions (30 minutes per week) * Perform exercises at home (3x10 minutes per week). * Fill out a daily questionnaire on pain and exercise adherence.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Lucerne, Canton of Lucerne, 6002, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Individuals who
Exclusion criteria
Individuals who …
The study intervention is a 4-week personalized physical back training program. The study intervention consists of six exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are selected through a clinical reasoning process, i.e., they are tailored and problem-oriented, based on the results of a clinical assessment.
The control intervention is a 4-week non-personalized physical back training program. The control intervention consists of six exercises selected from a predefined set by a physical therapist or medical doctor. These exercises are not selected through a clinical reasoning process, i.e., they are neither tailored nor problem-oriented nor based on the results of a clinical assessment.
Time frame: Baseline
Response time (in days).
Time frame: Baseline
Ratio of invited individuals to included participants.
Time frame: Baseline to 4 weeks
Analyze sample characteristics (e.g., gender, age) using descriptive statistics.
Time frame: Baseline to 4 weeks
Qualitatively evaluate the access of study personnel to necessary documents and the database through interviews.
Time frame: Baseline to 4 weeks
Qualitatively evaluate the usability of the questionnaire through interviews.
Time frame: Baseline to 4 weeks
Qualitatively evaluate the usability of the clinical assessment through interviews.
Time frame: Baseline to 4 weeks
Qualitatively assess the acceptability and suitability of the intervention and study procedures through interviews.
Time frame: Baseline to 4 weeks
Qualitatively evaluate the time and personnel required for conducting the study through interviews.
Time frame: Baseline to 4 weeks
Change in Patient-specific Functional Scale (PSFS), most bothersome activity. Range from 0 (unable to perform due to NSLBP) to 10 (able to perform at the same level as before NSLBP).
Time frame: Baseline to 4 weeks
Change in Roland Morris Disability Questionnaire (RMDQ). Range from 0 (no disability) to 24 (maximum disability).
Time frame: Baseline to 4 weeks
Change in EQ Visual Analogue Scale (EQ-VAS). Range from 0 (lowest health-related quality of life) to 100 (highest health-related quality of life).
Time frame: Baseline to 4 weeks
Change in 5-Level EuroQoL5D version (EQ-5D-5L). Range from 0 (lowest health-related quality of life) to 1 (highest health-related quality of life).
Time frame: Baseline to 4 weeks
Change in pain intensity (11-point Numeric Rating Scale, NRS). Range from 0 (no pain) to 10 (pain as bad as you can imagine). Recall period: 7 days.
Time frame: During the 4 week intervention period
Number of serious adverse events (SAE) and adverse events (AE) that are deemed possibly, probably, or definitely related to the intervention (according to ClinO, Art. 63, Switzerland).
Time frame: Baseline to 4 weeks
Change in number of episodes with NSLBP. Numerically, with 0 = minimum. Recall period: 7 days.
Time frame: Baseline to 4 weeks
Change in pain duration (e.g., average duration of an episode of NSLBP within the last 7 days). In minutes, hours, or days, with 0 = minimum. Recall period: 7 days.
Time frame: Baseline to 4 weeks
Change in Pain, Enjoyment, and General Activity (PEG) 3-Item Scale. Range from 0 (no pain; does not interfere) to 10 (pain as bad as you can imagine; completely interferes). Recall period: 7 days.
Time frame: Baseline to 4 weeks
Change in pain extent. Percentages of the body with NSLBP, with 0%=minimum
Time frame: Baseline to 4 weeks
Change in pressure pain threshold. kPA, with 0=minimum
Time frame: Baseline to 4 weeks
Change in range of motion. Degrees, with 0=minimum
Time frame: Baseline to 4 weeks
Change in strength. Nm, with 0=minimum
Time frame: Baseline to 4 weeks
Change in neurodynamics. Positive, negative.
Time frame: Baseline to 4 weeks
Change in movement control. Positive, negative.
Time frame: Baseline to 4 weeks
Change in Work Productivity and Activity Impairment Questionnaire (WPAI). Percentages, with 0%=no work productivity loss.
Time frame: Baseline to 4 weeks
Change in participant satisfaction (e.g., 1) I am satisfied with the training program I received. 2) I am satisfied with the result of the training program). 5-point Likert scale (strongly agree, agree, uncertain, disagree, strongly disagree).
Universität Luzern
Other
Acronym: LIFDI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04257253
Atrophy, Back Pain
Montreal, Quebec, Canada
View Trial DetailsNCT06938568
Back Pain, Behavior
Lucerne, Canton of Lucerne, Switzerland
View Trial DetailsNCT07441018
Back Pain, Core Stability
Lahore, Pakistan
View Trial DetailsNCT04570280
Arthritis, Arthritis, Rheumatoid
Istanbul, Turkey (Türkiye)
View Trial Details